4-nitroquinoline-1-oxide has been researched along with penicillamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Audic, N; Ermolenko, L; Franck, G; Garcia-Alvarez, MC; Martin, MT; Nhiri, N; Potier, P; Sasaki, NA; Wang, Q | 1 |
| Needleman, BW; Schwartz, S; Wasserman, SS; Wolff, DJ | 1 |
2 other study(ies) available for 4-nitroquinoline-1-oxide and penicillamine
| Article | Year |
|---|---|
N-Terminal 2,3-diaminopropionic acid (Dap) peptides as efficient methylglyoxal scavengers to inhibit advanced glycation endproduct (AGE) formation.
Topics: beta-Alanine; Chromatography, High Pressure Liquid; Electrophoresis, Polyacrylamide Gel; Glycation End Products, Advanced; Magnetic Resonance Spectroscopy; Peptides; Pyruvaldehyde | 2009 |
Spontaneous and clastogen induced chromosomal breakage in scleroderma.
Topics: 4-Nitroquinoline-1-oxide; Adult; Aged; Bleomycin; Cells, Cultured; Chromosome Aberrations; Chromosome Disorders; Chromosomes; DNA Damage; Female; Humans; Lymphocytes; Male; Middle Aged; Mitomycins; Mutagens; Penicillamine; Scleroderma, Systemic; Streptonigrin | 1991 |